Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arley Peter is active.

Publication


Featured researches published by Arley Peter.


Circulation | 2004

Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles.

Alexandre Ferreira; Arley Peter; Armando J. Mendez; Joaquin J. Jimenez; Lucia M. Mauro; Julio A. Chirinos; Reyan Ghany; Salim S. Virani; Santiago Garcia; Lawrence L. Horstman; Joshua Purow; Wenche Jy; Yeon S. Ahn; Eduardo de Marchena

Background—This study evaluated a possible relationship between levels of endothelial microparticles (EMPs), known to be a sensitive indicator of endothelial disturbance, and changes in postprandial lipid levels in healthy volunteers after a low- or high-fat meal. Methods and Results—Eighteen healthy subjects without known cardiovascular risk factors were evaluated. Lipid and EMP levels were measured before and 1 and 3 hours after a single low- or high-fat isocaloric meal. The low-fat meal had no significant postprandial effect on EMPs or lipids compared with fasting levels. In contrast, a single high-fat meal significantly increased EMP levels after 1 and 3 hours, from 389±54 (thousands per milliliter) when fasting to 541±139 (P=0.0002) and 677±159 (P<0.0001), respectively, and correlated with a postprandial elevation in serum triglycerides. Conclusions—A single high-fat meal led to a significant elevation of plasma EMP levels in healthy, normolipidemic subjects and correlated with a postprandial elevation of serum triglycerides. EMPs may be an indirect marker of endothelial dysfunction or injury induced by postprandial triglyceride-rich lipoproteins.


The Annals of Thoracic Surgery | 2003

Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center

Alexandre Ferreira; Arley Peter; Tomas A. Salerno; Hooshang Bolooki; Eduardo de Marchena

BACKGROUND The long-term benefits of angioplasty are limited by the occurrence of restenosis. Drug-eluting stents with a projected restenosis rate of close to 0% are soon to become available. The short- and long-term consequences of this advance to the cardiac surgical volume remain unclear. METHODS A total of 196 consecutive coronary angiograms and medical records of patients referred for coronary bypass surgery were reviewed. Considering the hypothetical premise of having drug-eluting stents with a near zero restenosis rate, we reviewed each case to determine if surgical revascularization was still the preferred option for revascularization. RESULTS The mean age was 60 (+/-10.6) years. Seventy-two percent of patients were male. Considering the availability of drug-eluting stents 154 (79%) would still have been sent to surgery, representing a 21% decrease in the number of surgical revascularizations. Angiographic characteristics predicting coronary bypass revascularization were the presence of chronic total occlusion (odds ratio [OR]: 9.1; confidence interval [CI]: 2.1 to 39), left main coronary artery stenosis (OR: 9.6; CI: 1.27 to 73), and need for valvular surgery (OR: 7.38; CI: 1.3 to 157). The most common predictors of a change in clinical management from surgical to percutaneous revascularization if drug-eluting stents were available were diffuse coronary narrowing (OR: 15.78), restenotic lesions (OR: 27.86), and small coronary arteries (OR: 26). CONCLUSIONS Drug-eluting stents may have a significant impact on cardiac surgery volume (approximately a 21% decrease in our center). It may also direct patients with small vessels, diffuse narrowing, or restenotic lesions and diabetic patients to percutaneous therapy.


Arquivos Brasileiros De Cardiologia | 2004

Hipovolemia grave como causa de insuficiência mitral aguda

Alexandre Ferreira; Arley Peter; Simon Chakko; Howard J. Willens; Eduardo de Marchena

We report a patient with profound hypovolemia who developed dynamic left ventricular outflow tract obstruction and severe mitral regurgitation. Both the outflow tract obstruction and mitral regurgitation resolved with volume replacement. Unlike previous reports of dynamic left ventricular outflow obstruction and mitral regurgitation, the degree of mitral regurgitation was severe. Possible mechanisms are discussed.


American Journal of Cardiology | 2004

Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non–ST-elevation acute coronary syndromes

Santiago Garcia; Mariana Canoniero; Arley Peter; Eduardo de Marchena; Alexandre Ferreira


International Journal of Cardiology | 2006

Internal mammary artery to pulmonary vasculature fistula—Case series

Arley Peter; Alexandre Ferreira; Kenneth Zelnick; Afolabi Sangosanya; Julio A. Chirinos; Eduardo de Marchena


Heart Disease | 2003

Arrhythmogenic right ventricular dysplasia in the elderly.

Alexandre Ferreira; Santiago Garcia; Melissa A. Pasquale; Mariana Canoniero; Arley Peter


Texas Heart Institute Journal | 2005

Ruptured Aneurysm of the Noncoronary Sinus of Valsalva

Dalton Miranda; Arley Peter; Jose Osorio; Alexandre Ferreira


Chest | 2006

IS DIABETES A STRONGER PREDICTOR OF RECURRENT CARDIOVASCULAR EVENTS THAN THE ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE

Julio A. Chirinos; Eduardo de Marchena; Anila Veerani; Arley Peter; Nasser Khan; Alan Schob; Alex Ferreira; Simon Chakko


Chest | 2006

DIFFERENTIAL ELEVATION OF ENDOTHELIAL MICROPARTICLES AND THEIR BINDING TO LEUKOCYTES IN ACUTE CORONARY SYNDROMES

Julio A. Chirinos; Eduardo de Marchena; Alex Ferreira; Carlos Alfonso; Anila Veerani; Arley Peter; Rene Parraga; Wenche Jy; Joaquin J. Jimenez; Lawrence L. Horstman; Yeon S. Ahn


Society of Nuclear Medicine Annual Meeting Abstracts | 2007

Absence of coronary calcification is associated with a normal myocardium perfusion study in patients with chest pain in a community hospital chest pain center

Warren R. Janowitz; Jack A. Ziffer; Arley Peter; Mehul Bhatt; Jose Osorio; Hao Vuong; Larry Elgaresta

Collaboration


Dive into the Arley Peter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julio A. Chirinos

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge